1990
|
Law 8,080/1990 (Art. 15 § XIX)
|
Defines that it is the responsibility of SUS to foster research and studies in health-related areas. |
1994
|
1st CNCTIS
|
1st National Conference on Science, Technology and Innovation in Health - promoted the institutionalization of the political debate of SUS responsibilities in fostering R&D/H. |
1999
|
Sector Funds
|
Funding for research, development and innovation projects. The Healthcare area is responsible for: CT-Health, CT-Infrastructure, CT-Biotechnology, CT-Green/Yellow, and for all cross-sectional activities involving more than one fund. |
2001
|
Millennium Institute Programs
|
Stimulates the development of inter-laboratory research networks to capture all of the potential of the existing physical infrastructure. |
2004
|
2nd CNCTIS
|
2nd National Conference on Science, Technology and Innovation in Health - brought together the goals of the National Healthcare Policy and those of the National Policy for Science and Technology, increasing the interaction between Health, Education, Science and Technology. |
PNCTIS
|
National Policy for Science, Technology and Innovation in Health - defines that national development in ST&I/H proceed sustainably, supported on the production of technical and scientific knowledge adjusted to the economic, social, cultural and political needs of the country. |
ANPPS
|
The National Agenda of Healthcare Research Priorities guides the research priorities to be promoted, according to the principles of the unified system (SUS). |
Law 10,973/20204 - Innovation Law
|
Defines measures to incentivize ST&I within the productive environment for developing capabilities and enabling the country to achieve technological and industrial development autonomy. |
PITCE
|
The National Policy for Industry, Technology and Foreign Trade defines innovation as a core dimension of the manufacturing and foreign trade policy. |
Law 11,105/2004 Biosafety Law
|
Sets safety guidelines and defines mechanisms to oversee activities involving Genetically Modified Organisms (GMO) and their derivatives. |
2005
|
Law 11,196/2005 “Lei do Bem” (Law of the Good)
|
Provides tax incentives for technological innovation. |
2006
|
Economic Subvention Program
|
Fosters innovation and increased competition among the nation’s companies and its economy. |
2007
|
PACTI (2007- 2010)
|
Action Plan for Science, Technology and Innovation, sought to increase scientific and technological production in the country. |
2008
|
PDP
|
Production Development Policy - improves the various sectors of Economic Industrial Complex, including partnerships between businesses and universities. |
GM/MS Directive 1,942/2008 GECIS
|
Created the Industrial Healthcare Complex Executive Group to implement the Brazilian framework governing strategies to strengthen the CEIS, the Production and Innovation in Healthcare Complex. |
INCT Program
|
Program of the National Institutes for Science and Technology. 82 INCT in health-related areas, out of 252 incentivized in 2016. |
GM/MS Directive 978/2008
|
Selects the projects that are strategic for SUS. Prioritizes promotion of RD&I and the manufacture of vaccines, blood derivatives and products for neglected diseases. |
2009
|
PNGTS
|
The National Policy for Technology Management in Healthcare promotes management activities related to the assessment, incorporation, disclosure, management, use and withdrawal of technologies within the healthcare system. |
Law 12,101/2009 Proadi - SUS
|
Created the Program to Support the Institutional Development of SUS (Proadi - SUS), supporting research strategic for SUS with tax exemption funds. This includes the Hospitals of Excellence program. |
2010
|
Law 12,349;2010 - Government Purchases Law
|
Promotes the replacement of imported manufactured goods and services with domestic ones resulting from technological innovation and development performed in Brazil. |
2010
|
National Graduate Studies Plan (2011-2020)
|
Prioritizes R&D in health-related areas, promotes research combining graduate studies, businesses and society, stimulates university-business partnerships, promotes international cooperation, contributes to strengthening the National Institutes of Science and Technology and the Research, Dissemination and Innovation Centers; promotes a stronger National Network of Clinical Research.
|
2011
|
PESS Agenda
|
The agenda for Research Strategic to the healthcare System defines the SUS lines of research to meet the strategic goals of the 2012- 2015 Multi-Year Plan. |
The 2011-2014 Greater Brazil Program
|
Strengthened the manufacturing, innovation and national competitive chains, following the PDP and PITCE lines of action to support, develop and implement business technology portfolios. |
Law 12,401/2012
|
Created Conitec, the SUS National Committee to Incorporate Technologies. This committed advises the MoH in the incorporation, exclusion or changes in new healthcare technologies within SUS. |
2012
|
National CTI Strategy for 2012-2015
|
Enhanced business innovation and consolidated the National Innovation System. |
GM/MS Directive n°. 4/10
|
Defined guidelines and criteria for production development partnerships; fostered partnerships between public and private institutions, encouraging technology transfer to Brazil. |
CNS Resolution 466/2012
|
Governs guidelines and standards of research involving human beings. |
Law 12,715/2012 Pronon and Pronas/ PCD
|
Created the National Program to Support Oncological Care (Pronon) and the National Program to Support Healthcare for People with Special Needs (Pronas/PCD), which encourages actions and services developed by private, non-profit entities, associations and foundations in the areas of oncology and people with special needs, using funds coming from Income Tax deductions. |
2013
|
INOVA-SAÚDE (2013-2017)
|
This program supports RD&I in public and private institutions working within CEIS, enabling continued funding of projects with the potential of reducing the nation’s technological dependence in inputs used for healthcare. |
GM/MS Directive n°. 3,089
|
Prioritizes scientific and technological development of biomaterials and items related to oncology, non-transmissible chronic diseases, neglected diseases, viral diseases, STDs and AIDS. |
Decree 8.065/2013 § 31
|
Stipulates that the Department of Science and Technology (Decit) will be involved in formulating, implementing and assessing PNCTIS, based on the requirements of the PNS and within the SUS principles and guidelines; coordinate and execute MoH activities in health-related R&D and promote inter-sector articulation within the National System of Science and Technology. |
GM/MS Directive n°. 2,531/2013
|
Redefines the list of priority items for SUS investments in R&D and manufacture, and creates the PDP. |
PNPC
|
National Knowledge Platform Program, supports partnerships between businesses and science and technology research institutions in Brazil and abroad for on-demand technology and innovative products, processes or services involving a technological risk. |
2015
|
CNS Resolution nº. 506/ 2016
|
Regulates the accreditation of Research Ethics Committees (REC), which make up the REC/CONEP System and provides other guidelines. |
Constitutional Amendment nº. 85/2015
|
National S&T Code - amends and adds provisions to the Federal Constitution to update how the activities of Science, Technology and Innovation are handled. |
2016
|
Law 13,243;2016
|
SC&I Legal Framework governing stimulus to scientific development, research, and the development of capabilities in science, technology and innovation. |